中成药治疗抑郁障碍临床应用指南

标题: 中成药治疗抑郁障碍临床应用指南
title: Guidelines for clinical application of Chinese patent medicine for depressive disorders
版本: 原创版
version: Original
分类: 中医药指南
classification: Traditional Chinese Medicine guideline
领域: 诊疗
field: Diagnosis and Treatment
国家和地区: 中国
Country and region: China
指南使用者: 临床医生
Guide users: Clinician
证据分级方法: Grade 评价
Evidence grading method: Grade evaluation
制定单位: 北京中医药大学东方医院
Formulating unit: Dongfang Hospital BeiJing University of Chinese Medicine
注册时间: 2021-11-06
Registration time:
注册编号: IPGRP-2021CN349
Registration number:
指南制订的目的: 中成药治疗抑郁症具有起效时间早、疗效明显、副作用少等优点,对于阈下抑郁、轻度抑郁症,部分中成药可替代西药治疗。在西医治疗方案中,中成药联合西药治疗可提高抗抑郁疗效,减少西药的副作用,起到了增效减毒的作用。 目前国际上尚无中成药治疗抑郁症的临床诊疗指南,临床工作中诊治标准不统一,导致运用 中医药诊治抑郁症的临床行为不规范,影响中成药治疗抑郁症的有效性及临床经验的总结,更无法充分体现其优势性,并阻碍了中成药方案诊治抑郁症在国际范围内的交流。参考国际上关于抑郁症的诊断标准及治疗规范,结合目前中医药防治抑郁症研究成果和成功经验,借鉴现代医学临床流行病学和循证医学的研究方法,制定具有循证医学证据的中成药治疗抑郁症的临床应用指南。推荐具有循证医学证据和中医神志病学专家共识的抑郁症的中成药临床应用指南,旨在指导临床医生及护理人员规范使用中成药方案,加强对抑郁症的治疗管理,改善患者的的心身健康、社会交往、职业能力及躯体活动,全面提高生活质量。提高在世界范围内运用中成药方法诊治抑郁症的整体水平,减少抑郁症造成的家庭经济负担和社会危害性。
Purpose of the guideline: The treatment of depression with proprietary Chinese medicines has the advantages of early onset of action, evident efficacy, and few side effects. For subthreshold depression and mild depression, some proprietary Chinese medicines can replace western medicine treatment. In the west of medical treatment program, the combination of proprietary Chinese medicine with western medicine treatment can improve the antidepressant efficacy and reduce the side effects of western medicine, which plays a role in increasing the effectiveness and toxicity. Currently, there is no international clinical guideline for the treatment of depression with proprietary Chinese medicine. The clinical standard of treatment is not uniform, which leads to irregular clinical behavior in the treatment of depression with proprietary Chinese medicine, which affects the effectiveness of the treatment of depression with proprietary Chinese medicine and the summary of clinical experience, and cannot fully reflect its advantages, and hinders the international exchange of the treatment of depression with proprietary Chinese medicine. Concerning the international diagnostic criteria and treatment norms for depression, combined with the current research results and successful experiences of TCM in preventing and treating depression, and drawing on the research methods of modern medical clinical epidemiology and evidence-based medicine, the clinical application guidelines of TCM for depression with evidence-based medicine are formulated. The aim is to guide clinicians and nursing staff to standardize TCM protocols, enhance the therapeutic management of depression, improve patients' mental and physical health, social interaction, occupational ability, and physical activity, and improve the overall quality of life. The aim is to improve the general level of diagnosis and treatment of depression using proprietary Chinese medicine globally and reduce the economic burden of depression on families and the social harm caused by depression.